ICONOVO is a Swedish privately funded device company with a business model to supply the market with unique, safe and cost efficient inhalation devices. ICONOVO has long and unique experience and capability in the development of inhalation devices. ICONOVO’s products combine technical complexity with user friendly and attractive design. ICONOVO’s ambition is to become a leading supplier on a global market and to within 5 years achieve a multimillion turnover and a positive result.
ICONOVO started as a part of Zenit Medical, a business unit within Zenit Design since 2010. Zenit Design has for many years successfully worked with the development of inhalation devices. When AstraZeneca closed down the Lund site and relocated the inhalation R&D to Mölndal, two key individuals from AstraZeneca joined Zenit Design and formed Zenit Medical. Over three years several concepts have been developed making up a family of innovative inhalation devices. In 2013 ICONOVO AB was formed to develop and commercialize the inhalation devices.